Pharmafile Logo
Pharmafocus logo
Advanced Search
HPV vaccine image

GAVI begins roll-out of cheap HPV vaccine

October 17, 2013
Sales and Marketing GAVI, HPV, Vaccine

For the first time women in parts of the world with the highest cervical cancer death rate will be able …

News
screen_shot_2013-10-17_at_08

Director appointed for MediCity

October 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing browning, medicity

Former chief executive of Philips Healthcare and Consumer Lifestyle David Browning has been appointed director of MediCity. The new Nottingham-based …

Appointment
Regeneron image

Phase III boost for alirocumab

October 17, 2013
Sales and Marketing LDL, Regeneron, alirocumab

Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …

News
NHS image

Patients should ‘top up’ NHS costs

October 16, 2013
Sales and Marketing Dixon, England, NHS, NICE, top up

A leading doctor believes that NHS patients must produce top up payments for treatments for non-life threatening conditions. Speaking at …

News

Rare disease fund scrapped by NHS England

October 16, 2013
Research and Development, Sales and Marketing NHS England, fund, rare diseases

NHS England has pulled the plug on a £50 million fund to advance innovation in the investigation and treatment of …

News
mark_mcclellan_jj_fda

Former FDA commissioner joins J&J

October 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, J&J, JJ

Johnson & Johnson has announced that ex-FDA commissioner Mark McClellan has been appointed to its Board of directors. Dr McClellan …

Appointment
jj_2johnson_and_johnson

Johnson & Johnson posts strong Q3 results

October 16, 2013
Sales and Marketing J&J, JJ, Q3, Velcade, results

Johnson & Johnson has posted a strong set of financials for the third quarter as new products from its pharma …

News
set your sights image

Novartis launches Facebook ‘retina app’

October 15, 2013
Medical Communications AMD, Bayer, Lucentis, Novartis, set your sights

Novartis, the world’s biggest eye-care drugmaker, has launched a new Facebook retina app to raise awareness of retinal disease. The …

News
astrazeneca image

AstraZeneca pays $460m for cancer specialists

October 15, 2013
Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen

AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …

News

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

News
Pixuvri image

Price cut not enough for Pixuvri

October 15, 2013
Sales and Marketing Cell Therapeutics, NICE, pixuvri

NICE is still saying no to Cell Therapeutics’ lymphoma drug Pixuvri, despite the firm offering a discount on the treatment’s …

News
Roche image

Roche poised to get even bigger in biomanufacturing

October 15, 2013
Manufacturing and Production Jobs, Merck, Roche, cuts

Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …

News
ian_tomlinson_bia_web

String of appointments to BIA Board

October 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, appointments

The BioIndustry Association has appointed Kevin Cox, Donna Hackett, Jane Osbourn, Stephen Taylor, Patrick Verheyen and Tim Watts to its …

Appointment
Ranbaxy image

FDA throws Ranbaxy a manufacturing lifeline

October 15, 2013
Manufacturing and Production FDA, Ranbaxy, recall

Problems have plagued Ranbaxy’s manufacturing operations in the last couple of years, but it enjoyed a bit of light relief …

News

Boehringer submits NSCLC pill

October 14, 2013
Sales and Marketing

Boehringer Ingelheim has submitted its oral triple angiokinase inhibitor nintedanib for scrutiny by the European Medicines Agency. Nintedanib was impressive …

News
Eric Low image

Trials and tribulations

October 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, eric low, myeloma, transparency

I have been chief executive of Myeloma UK since its inception 17 years ago, and its unique bedside to bench …

Feature
ben_atkins_inventiv

inVentiv Health creates two senior appointments



October 14, 2013
Medical Communications, Research and Development, Sales and Marketing inVentiv Health

The comms division of inVentiv Health has appointed two 
social media veterans to expand its digital footprint. Emma D’Arcy joins …

Appointment
zytiga image

Janssen agrees Zytiga deal

October 14, 2013
Sales and Marketing AstraZeneca, Janssen, Zytiga

Janssen has agreed to co-promote its once-daily prostate cancer pill Zytiga with AstraZeneca in Japan for an undisclosed sum. A …

News

Vetter swells filling capacity with $100m investment

October 11, 2013
Manufacturing and Production API, Vetter, sterile liquid

German contract development and manufacturing organisation (CDMO) Vetter says it is planning to invest over $100 million across its production …

News
pfizer image

Mixed tale for Pfizer psoriasis drug

October 11, 2013
Sales and Marketing Enbrel, Pfizer, psoriasis, tofacitinib

Pfizer has seen its novel, oral Janus kinase (JAK) inhibitor tofacitinib turn in a mixed showing in late-stage trials in …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026